Skip to main content

NeuroOne Medical Technologies Corporation

corporate_fare Company Profile

NeuroOne Medical Technologies Corporation

NMTC·NASDAQ·Industrial Applications And Services·CIK 0001500198

NEUROONE MEDICAL TECHNOLOGIES Corp is a medical technology company specializing in diagnostic, ablation, and deep brain stimulation technology for brain-related conditions like epilepsy and Parkinson's disease. The company also focuses on ablation and stimulation for pain management throughout the body, and drug delivery systems that include diagnostic and stimulation capabilities. NEUROONE MEDICAL TECHNOLOGIES Corp has received 510(k) clearance from the Food and Drug Administration (FDA) for four devices. These include the Evo cortical electrode technology, used for temporary (less than 30 days) recording, monitoring, and stimulation on the brain's surface, and the Evo sEEG electrode technology, for temporary (less than 30 days) recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain. Additionally, the company has clearance for its OneRF Brain Ablation System, which creates radiofrequency lesions in nervous tissue for functional neurosurgical procedures, and the OneRF TN Ablation System, used for creating radiofrequency lesions for pain treatment or functional neurosurgical procedures. The company has a distribution agreement with Zimmer, Inc., granting Zimmer Biomet Holdings, Inc. a license to commercialize and distribute the Evo Cortical, Evo sEEG, and OneRF Brain Ablation System for brain applications. A limited market release of the OneRF TN Ablation System began in December 2025. Other products and indications are currently under development. The company's products include thin film electrode technology, such as cortical sheet and depth electrodes, which are vital for diagnosing neurological disorders like epilepsy, Parkinson's disease, dystonia, and essential tremors. The Evo Cortical portfolio includes various contact configurations of strip and grid electrodes.

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for NMTC at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • NeuroOne Reports Significant Loss, Going Concern Warning, and Nasdaq Delisting Risk

Financial Snapshot

Fiscal year ended September 30, 2025
Revenue
$9.1M
Net Income
-$3.61M
Diluted EPS
-$0.09
Op. Cash Flow
-$2.84M
Free Cash Flow
-$2.92M
Gross Profit
$5.14M
Operating Income
-$4.23M
Cash & Equivalents
$6.57M
Debt / Equity
0.00×
Net Margin
-39.6%
Shares Outstanding
50.01M sh
Source: 10-K · filed 2026-01-23 · accession 0001213900-26-007245
$0.6521
52-week range · as of 2026-08-13 $0.6521 – $6.96
Market cap
$5.94M
Volume
98.6K (1.5× avg)
3-mo avg 67.9K
Live data · 2026-11-22 12:46 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed NMTC - Filings & News (Page 2)

NMTC
Feb 17, 2026, 7:01 AM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.796999
Real-time Price: $0.6521 info
Change: Reverse Stock Split info
Market Cap: $5.938M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets